Participants 45 95 3
anemic cancer patients on combination chemotherapy
Participants 109 190 4
Patients with advanced cancer frequently experience clinically significant anemia
Participants 823 923 4
patients with advanced cancer who were receiving myelosuppressive chemotherapy (excluding cisplatin)
Participants 944 1012 5
153 anemic cancer patients receiving cyclic combination chemotherapy
